Inversely, the transfection of UTR2 in cancer cells can also modulate SHMT1 activity and reduce cell viability, suggesting that it is of great necessity for us to give more studies on the relationship between SHMT1 and SHMT2. This evidence concerns the gene SHMT2 and cancer.